SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Elusys Therapeutics, Inc. Awarded $68 Million Contract to Develop Anthim for Intramuscular Pre- and Post-Exposure Prophylaxis of Anthrax Infection